Search Results - Lynette Keyes‐Elstein

  • Showing 1 - 17 results of 17
Refine Results
  1. 1
    Practice based education to improve delivery systems for prevention in primary care: randomised trial

    Practice based education to improve delivery systems for prevention in primary care: randomised trial by Peter A. Margolis, Carole Lannon, Jayne Stuart, Bruce J. Fried, Lynette Keyes-Elstein, Donald E. Moore

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial

    Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial by Kevan C. Herold, Stephen E. Gitelman, Mario R. Ehlers, Peter A. Gottlieb, Carla J. Greenbaum, William Hagopian, Karen D. Boyle, Lynette Keyes-Elstein, Sudeepta Aggarwal, Deborah Phippard, Peter H. Sayre, James McNamara, Jeffrey A. Bluestone

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone

    A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone by Russell P. Hall, Janet A. Fairley, David T. Woodley, Victoria P. Werth, Deborah L. Hannah, Robert D. Streilein, Julie McKillip, Joyce Okawa, Mathew Rose, Lynette Keyes-Elstein, Ashley Pinckney, A. Overington, Josiah F. Wedgwood, Linna Ding, B. Welch

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Machine learning predicts stem cell transplant response in severe scleroderma

    Machine learning predicts stem cell transplant response in severe scleroderma by Jennifer M. Franks, Viktor Martyanov, Yue Wang, Tammara Wood, Ashley Pinckney, Leslie J. Crofford, Lynette Keyes-Elstein, Daniel E. Furst, Ellen Goldmuntz, Maureen D. Mayes, Peter A. McSweeney, Richard A. Nash, Keith M. Sullivan, Michael L. Whitfield

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Randomized, Double‐Blind, Placebo‐Controlled Trial of the Effect of Vitamin D<sub>3</sub> on the Interferon Signature in Patients With Systemic Lupus Erythematosus

    Randomized, Double‐Blind, Placebo‐Controlled Trial of the Effect of Vitamin D<sub>3</sub> on the Interferon Signature in Patients With Systemic Lupus Erythematosus by Cynthia Aranow, Diane L. Kamen, Maria Dall’Era, Elena Massarotti, Meggan Mackay, Fotios Koumpouras, Andreea Coca, W. Winn Chatham, Megan E. B. Clowse, Lisa Criscione‐Schreiber, Sherri Callahan, Ellen Goldmuntz, Lynette Keyes‐Elstein, Michaela Oswald, Peter K. Gregersen, Betty Diamond

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial

    Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial by Stephen E. Gitelman, Peter A. Gottlieb, Eric I. Felner, Steven M. Willi, Lynda K. Fisher, Antoinette Moran, Michael Gottschalk, Wayne V. Moore, Ashley Pinckney, Lynette Keyes-Elstein, Kristina M. Harris, Sai Kanaparthi, Deborah Phippard, Linna Ding, Jeffrey A. Bluestone, Mario R. Ehlers

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial

    Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial by Stephen E. Gitelman, Peter A. Gottlieb, Mark Rigby, Eric I. Felner, Steven M. Willi, Lynda K. Fisher, Antoinette Moran, Michael Gottschalk, Wayne V. Moore, Ashley Pinckney, Lynette Keyes-Elstein, Sudeepta Aggarwal, Deborah Phippard, Peter H. Sayre, Linna Ding, Jeffrey A. Bluestone, Mario R. Ehlers

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts

    Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts by Elizabeth R. Volkmann, Donald P. Tashkin, Myung‐Shin Sim, Ning Li, Ellen Goldmuntz, Lynette Keyes-Elstein, Ashley Pinckney, Daniel E. Furst, Philip J. Clements, Dinesh Khanna, Virginia Steen, Dean E. Schraufnagel, Shiva Arami, Vivien Hsu, Michael D. Roth, Robert M. Elashoff, Keith M. Sullivan

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Clinical Efficacy and Safety of Baminercept, a Lymphotoxin β Receptor Fusion Protein, in Primary Sjögren's Syndrome

    Clinical Efficacy and Safety of Baminercept, a Lymphotoxin β Receptor Fusion Protein, in Primary Sjögren's Syndrome by E. William St. Clair, Alan N. Baer, Chungwen Wei, Ghaith Noaiseh, A. L. Parke, Andreea Coca, Tammy O. Utset, Mark C. Genovese, Daniel J. Wallace, James McNamara, Karen Boyle, Lynette Keyes‐Elstein, Jeffrey L. Browning, Nathalie Franchimont, Kira Smith, Joel M. Guthridge, Igñacio Sanz, Judith A. James

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis–associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial

    Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis–associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized,... by Roham T. Zamanian, David B. Badesch, Leland W.K. Chung, Robyn T. Domsic, Thomas A. Medsger, Ashley Pinckney, Lynette Keyes-Elstein, Carla D’Aveta, Meagan Spychala, R. James White, Paul M. Hassoun, Fernando Torres, Andrew J. Sweatt, Jerry A. Molitor, Dinesh Khanna, Holden T. Maecker, Beverly Welch, Ellen Goldmuntz, Mark R. Nicolls

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Myeloablation followed by autologous stem cell transplantation normalises systemic sclerosis molecular signatures

    Myeloablation followed by autologous stem cell transplantation normalises systemic sclerosis molecular signatures by Shervin Assassi, Xuan Wang, Guocai Chen, Ellen Goldmuntz, Lynette Keyes-Elstein, Binwu Ying, Paul K. Wallace, Jacob Turner, W. Jim Zheng, Virginia Pascual, John Varga, Monique Hinchcliff, Chiara Bellocchi, Peter A. McSweeney, Daniel E. Furst, Richard A. Nash, Leslie J. Crofford, Beverly Welch, Ashley Pinckney, Maureen D. Mayes, Keith M. Sullivan

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients

    Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients by Mark Rigby, Kristina M. Harris, Ashley Pinckney, Linda A. DiMeglio, Marc Rendell, Eric I. Felner, Jean M. Dostou, Stephen E. Gitelman, Kurt Griffin, Eva Tsalikian, Peter A. Gottlieb, Carla J. Greenbaum, Nicole Sherry, Wayne V. Moore, Roshanak Monzavi, Steven M. Willi, Philip Raskin, Lynette Keyes-Elstein, S. Alice Long, Sai Kanaparthi, Noha Lim, Deborah Phippard, Carol L. Soppe, Margret L. Fitzgibbon, James McNamara, Gerald T. Nepom, Mario R. Ehlers

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial

    Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial by Mark Rigby, Linda A. DiMeglio, Marc Rendell, Eric I. Felner, Jean M. Dostou, Stephen E. Gitelman, Chetanbabu M Patel, Kurt Griffin, Eva Tsalikian, Peter A. Gottlieb, Carla J. Greenbaum, Nicole Sherry, Wayne V. Moore, Roshanak Monzavi, Steven M. Willi, Philip Raskin, Antoinette Moran, William E. Russell, Ashley Pinckney, Lynette Keyes-Elstein, Michael Howell, Sudeepta Aggarwal, Noha Lim, Deborah Phippard, Gerald T. Nepom, James McNamara, Mario R. Ehlers

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Unique Sjögren’s syndrome patient subsets defined by molecular features

    Unique Sjögren’s syndrome patient subsets defined by molecular features by Judith A. James, Joel M. Guthridge, Hua Chen, Rufei Lu, Rebecka L. Bourn, Krista Bean, Melissa E. Munroe, Miles Smith, Eliza Chakravarty, Alan N. Baer, Ghaith Noaiseh, Ann L. Parke, Karen Boyle, Lynette Keyes-Elstein, Andreea Coca, Tammy O. Utset, Mark C. Genovese, Virginia Pascual, Paul J. Utz, V. Michael Holers, Kevin D. Deane, Kathy L. Sivils, Teresa Aberle, Daniel J. Wallace, James McNamara, Nathalie Franchimont, E. William St. Clair

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Gastric Antral Vascular Ectasia and Its Clinical Correlates in Patients with Early Diffuse Systemic Sclerosis in the SCOT Trial

    Gastric Antral Vascular Ectasia and Its Clinical Correlates in Patients with Early Diffuse Systemic Sclerosis in the SCOT Trial by Emily W. Hung, Maureen D. Mayes, Roozbeh Sharif, Shervin Assassi, Victor I. Machicao, Chitra Hosing, E. William St. Clair, Daniel E. Furst, Dinesh Khanna, Stephen J. Forman, Shin Mineishi, Kristine Phillips, James R. Seibold, Christopher Bredeson, Mary Ellen Csuka, Richard A. Nash, Mark H. Wener, Robert W. Simms, Karen K. Ballen, Sharon LeClercq, Jan Storek, Ellen Goldmuntz, Beverly Welch, Lynette Keyes-Elstein, Sharon Castina, Leslie J. Crofford, Peter A. McSweeney, Keith M. Sullivan

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes

    IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes by Carla J. Greenbaum, Elisavet Serti, Katharina Lambert, Lia J. Weiner, Sai Kanaparthi, Sandra Lord, Stephen E. Gitelman, Darrell M. Wilson, Jason L. Gaglia, Kurt Griffin, William E. Russell, Philip Raskin, Antoinette Moran, Steven M. Willi, Eva Tsalikian, Linda A. DiMeglio, Kevan C. Herold, Wayne V. Moore, Robin Goland, Mark Harris, Maria E. Craig, Desmond Schatz, David A. Baidal, Henry Rodriguez, Kristina M. Utzschneider, Hendrik J. Nel, Carol L. Soppe, Karen D. Boyle, Karen Cerosaletti, Lynette Keyes-Elstein, S. Alice Long, Ranjeny Thomas, James McNamara, Jane H. Buckner, Srinath Sanda

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma

    Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma by Keith Sullivan, Ellen Goldmuntz, Lynette Keyes-Elstein, Peter A. McSweeney, Ashley Pinckney, Beverly Welch, Maureen D. Mayes, Richard A. Nash, Leslie J. Crofford, Barry Eggleston, Sharon Castina, Linda M. Griffith, Julia Goldstein, Dennis Wallace, Oana Craciunescu, Dinesh Khanna, Rodney J. Folz, Jonathan Goldin, E. William St. Clair, James R. Seibold, Kristine Phillips, Shin Mineishi, Robert W. Simms, Karen K. Ballen, Mark H. Wener, George E. Georges, Shelly Heimfeld, Chitra Hosing, Stephen J. Forman, Suzanne Kafaja, Richard M. Silver, Leroy Griffing, Jan Storek, Sharon LeClercq, Richard Brasington, Mary Ellen Csuka, Christopher Bredeson, Carolyn A. Keever-Taylor, Robyn T. Domsic, M. Bashar Kahaleh, Thomas A. Medsger, Daniel E. Furst

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: